Evidence map›Paper›PMID 34465473›Full record

ArticleVaccine2021

COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.

Liesl M Hagan, Charles Dusseau, Michael Crockett, Tami Rodriguez, Michael J Long

Abstract read
In one paragraph

Article in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Compassionate Release and COVID-19: Analyzing Inconsistent Applications of the First Step Act by Federal Courts.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. COVID-19 Burden in Adult Correctional or Detention Facilities and the Surrounding Communities, January 1, 2020-July 20, 2021.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liesl M HaganCenters for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Viral Hepatitis, 1600 Clifton Road NE, Atlanta, GA 30333, United States; Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States. Electronic address: vqf8@cdc.gov.
Charles DusseauFederal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: cdusseau@bop.gov.
Michael CrockettFederal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: mcrockett@bop.gov.
Tami RodriguezFederal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: t1rodriguez@bop.gov.
Michael J LongFederal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: mzlong@bop.gov.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo describe COVID-19 vaccine distribution operations in United States Federal Bureau of Prisons (BOP) institutions and offices from December 16, 2020-April 14, 2021, report vaccination coverage among staff and incarcerated people, and identify factors associated with vaccination acceptance among incarcerated people.

methodsThe BOP COVID-19 vaccination plan and implementation timeline are described. Descriptive statistics and vaccination coverage were calculated for the BOP incarcerated population using data from the BOP electronic medical record. Coverage among staff was calculated using data from the Centers for Disease Control and Prevention Vaccination Administration Management System. Vaccination coverage in the BOP versus the overall United States adult population was compared by state/territory. Univariate and multivariable logistic regression models were developed to identify demographic, health-related, and institution-level factors associated with vaccination acceptance among incarcerated people, using hierarchical linear modeling to account for institution-level clustering.

resultsBy April 14, 2021, BOP had offered COVID-19 vaccination to 37,870 (100%) staff and 88,173/126,413 (69.8%) incarcerated people, with acceptance rates of 50.2% and 64.2%, respectively. At the time of analysis, vaccination coverage in BOP was comparable to coverage in the overall adult population in the states and territories where BOP institutions and offices are located. Among incarcerated people, factors associated with lower vaccination acceptance included younger age, female sex, non-Hispanic Black and Asian race/ethnicity, and having few underlying medical conditions; factors associated with higher acceptance included having a prior SARS-CoV-2 infection, being born outside the United States, and being assigned to a Federal Detention Center.

conclusionsEarly COVID-19 vaccination efforts in BOP have achieved levels of coverage similar to the general population. To build on this initial success, BOP can consider strategies including re-offering vaccination to people who initially refused and tailoring communication strategies to groups with lower acceptance rates.

Indexed as

COVID-19COVID-19 VaccinesAdultFemaleHumansPrisonsSARS-CoV-2United StatesVaccinationCOVID-19 VaccinesCOVID-19 vaccineFederal Bureau of PrisonsSARS-CoV-2

Identifiers

PMID34465473
PMCPMC8363472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.